Constantí Serrallonga
Director/Board Member at Archivel Farma SL
Constantí Serrallonga active positions
| Companies | Position | Start | End |
|---|---|---|---|
Archivel Farma SL
 Archivel Farma SL Miscellaneous Commercial ServicesCommercial Services Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain. | Director/Board Member | 2011-09-06 | - |
Career history of Constantí Serrallonga
Training of Constantí Serrallonga
| University of Barcelona | Undergraduate Degree |
Statistics
International
| Spain | 3 |
Operational
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Archivel Farma SL
Archivel Farma SL Miscellaneous Commercial ServicesCommercial Services Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain. | Commercial Services |
